These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25311739)

  • 41. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
    Atanackovic D; Luetkens T; Kloth B; Fuchs G; Cao Y; Hildebrandt Y; Meyer S; Bartels K; Reinhard H; Lajmi N; Hegewisch-Becker S; Schilling G; Platzbecker U; Kobbe G; Schroeder T; Bokemeyer C; Kröger N
    Am J Hematol; 2011 Nov; 86(11):918-22. PubMed ID: 21898529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genome-Wide Epigenetic Studies in Human Disease: A Primer on -Omic Technologies.
    Yan H; Tian S; Slager SL; Sun Z; Ordog T
    Am J Epidemiol; 2016 Jan; 183(2):96-109. PubMed ID: 26721890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia.
    Wang BH; Li YH; Yu L
    Chin Med J (Engl); 2015 Sep; 128(17):2395-403. PubMed ID: 26315090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic and epigenetic basis of chronic lymphocytic leukemia.
    Martín-Subero JI; López-Otín C; Campo E
    Curr Opin Hematol; 2013 Jul; 20(4):362-8. PubMed ID: 23719185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies.
    Zhang X; Lv D; Zhang Y; Liu Q; Li Z
    Oncotarget; 2016 Sep; 7(36):58586-58594. PubMed ID: 27474172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Am J Hematol; 2005 Dec; 80(4):282-7. PubMed ID: 16315255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecularly targeted therapy in acute myeloid leukemia.
    Bernasconi P; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Quarna J
    Ann N Y Acad Sci; 2004 Dec; 1028():409-22. PubMed ID: 15650266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deregulation of signaling pathways in acute myeloid leukemia.
    Scholl C; Gilliland DG; Fröhling S
    Semin Oncol; 2008 Aug; 35(4):336-45. PubMed ID: 18692684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
    Patel JL; Schumacher JA; Frizzell K; Sorrells S; Shen W; Clayton A; Jattani R; Kelley TW
    Leuk Res; 2017 May; 56():7-12. PubMed ID: 28152414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecularly targeted therapy in acute myeloid leukemia.
    Gill H; Leung AY; Kwong YL
    Future Oncol; 2016 Mar; 12(6):827-38. PubMed ID: 26828965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical applications of epigenetic markers and epigenetic profiling in myeloid malignancies.
    McDevitt MA
    Semin Oncol; 2012 Feb; 39(1):109-22. PubMed ID: 22289497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome-wide epigenomic profiling for biomarker discovery.
    Dirks RA; Stunnenberg HG; Marks H
    Clin Epigenetics; 2016; 8():122. PubMed ID: 27895806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single-Cell Genomics and Epigenomics: Technologies and Applications in Plants.
    Luo C; Fernie AR; Yan J
    Trends Plant Sci; 2020 Oct; 25(10):1030-1040. PubMed ID: 32532595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An integrated genomic approach to the assessment and treatment of acute myeloid leukemia.
    Godley LA; Cunningham J; Dolan ME; Huang RS; Gurbuxani S; McNerney ME; Larson RA; Leong H; Lussier Y; Onel K; Odenike O; Stock W; White KP; Le Beau MM
    Semin Oncol; 2011 Apr; 38(2):215-24. PubMed ID: 21421111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetic Therapies for Acute Myeloid Leukemia and Their Immune-Related Effects.
    Gambacorta V; Gnani D; Vago L; Di Micco R
    Front Cell Dev Biol; 2019; 7():207. PubMed ID: 31681756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Viewing AML through a New Lens: Technological Advances in the Study of Epigenetic Regulation.
    Godfrey LC; Rodriguez-Meira A
    Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A panoramic view of acute myeloid leukemia.
    Chen SJ; Shen Y; Chen Z
    Nat Genet; 2013 Jun; 45(6):586-7. PubMed ID: 23715324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetics: prognosis based on commitment signature.
    McCarthy N
    Nat Rev Cancer; 2014 Mar; 14(3):153. PubMed ID: 24561431
    [No Abstract]   [Full Text] [Related]  

  • 59. Tightly integrated genomic and epigenomic data mining using tensor decomposition.
    Fang J
    Bioinformatics; 2019 Jan; 35(1):112-118. PubMed ID: 29939222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Independence of epigenetic and genetic diversity in AML.
    Sasca D; Huntly BJ
    Nat Med; 2016 Jul; 22(7):708-9. PubMed ID: 27387883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.